Scarica l'app Stockscreener
3.30
5.44%
-0.19
Dopo l'orario di chiusura:
3.30
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.49
Aprire:
$3.46
Volume 24 ore:
1.10M
Relative Volume:
1.90
Capitalizzazione di mercato:
$149.85M
Reddito:
$103.00K
Utile/perdita netta:
$-51.85M
Rapporto P/E:
-0.6077
EPS:
-5.43
Flusso di cassa netto:
$-47.59M
1 W Prestazione:
-14.06%
1M Prestazione:
+48.65%
6M Prestazione:
+108.86%
1 anno Prestazione:
+67.51%
Intervallo 1D:
$3.13
$3.51
Intervallo di 1 settimana:
$3.13
$3.97
Portata 52W:
$1.36
$3.97
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
Nome
Checkpoint Therapeutics Inc
Settore
Industria
Telefono
781-652-4500
Indirizzo
95 SAWYER ROAD, WALTHAM, NY
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-14 | Ripresa | B. Riley Securities | Buy |
| 2021-06-09 | Iniziato | B. Riley Securities | Buy |
| 2021-01-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-05-29 | Iniziato | Lake Street | Buy |
| 2017-12-08 | Iniziato | H.C. Wainwright | Buy |
Checkpoint Therapeutics Inc Borsa (CKPT) Ultime notizie
What Analysts Were Expecting After Checkpoint Therapeutics Inc (NASDAQ: CKPT) rose 2.03% - Stocks Register
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus.com
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Short Interest Update - MarketBeat
Checkpoint Therapeutics stock hits 52-week high at $3.62 By Investing.com - Investing.com Australia
Checkpoint Therapeutics stock hits 52-week high at $3.62 - Investing.com
Checkpoint Therapeutics Inc (CKPT) Is A Good Stock To Invest In - Stocks Register
Boston-area biotechs await drug approval decisions in coming months - The Business Journals
Do investors need to be concerned about Checkpoint Therapeutics Inc (CKPT)? - US Post News
Checkpoint Therapeutics Inc [CKPT] CEO, President and Director makes an insider sale of 24,610 shares worth $50450.0. – Knox Daily - Knox Daily
Checkpoint Therapeutics Inc (CKPT)’s results reveal risk - US Post News
Janux Therapeutics Inc [JANX] Stock sold by Insider Avalon Ventures XI, L.P. for $5.18 million - Knox Daily
Understanding the Risks of Investing in Harrow Inc (HROW) - Knox Daily
Checkpoint Therapeutics Inc [CKPT] stock was sold by Oliviero James F III at the price of US$50450.0 - Knox Daily
Recent Insider Activity Suggests Potential Gains for Corcept Therapeutics Inc (CORT) - Knox Daily
Acadia Pharmaceuticals Inc (ACAD) Becoming More Attractive for Investors - Knox Daily
Gain Therapeutics Inc [GANX] Investment Guide: What You Need to Know - Knox Daily
Viridian Therapeutics Inc (VRDN) receives a Buy rating from Needham - Knox Daily
Liberty Energy Inc [LBRT] Investment Appeal on the Rise - Knox Daily
Surf Air Mobility Inc [SRFM] Investment Guide: What You Need to Know - Knox Daily
Recent Insider Activity Could Benefit Opendoor Technologies Inc (OPEN) - Knox Daily
Howmet Aerospace Inc [HWM] Insider Activity: An Update for Investors - Knox Daily
Zentalis Pharmaceuticals Inc [ZNTL] Insider Vultaggio Vincent sells 1,603 Shares – Company Insider Activity - Knox Daily
Checking in on TG Therapeutics Inc (TGTX) after recent insiders movement - Knox Daily
Investing in SS&C Technologies Holdings Inc (SSNC): What You Must Know - Knox Daily
KBR Inc [KBR] stock was sold by Ibrahim Jalal at the price of US$2.33 million - Knox Daily
Confluent Inc (CFLT) receives a Neutral rating from Robert W. Baird - Knox Daily
Alnylam Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
The Attractiveness of Investing In Cerence Inc (CRNC) is Growing - Knox Daily
PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily
KPTI’s latest rating updates from top analysts. - Knox Daily
Enphase Energy Inc (ENPH) receives a Mkt perform rating from William Blair - Knox Daily
Consol Energy Inc (CEIX) Becoming More Attractive for Investors - Knox Daily
Investing in Myriad Genetics, Inc. (MYGN): What You Must Know - Knox Daily
Rocket Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Citigroup’s latest rating for CPRX stock - Knox Daily
Goldman analysts downgrades a Neutral rating for Intellia Therapeutics Inc (NTLA) - Knox Daily
Examining the Potential Price Growth of Squarespace Inc (SQSP) - Knox Daily
An Analysis of Altimmune Inc (ALT)’s Potential Price Growth - Knox Daily
Zumiez Inc (ZUMZ) gets rating Downgrade from William Blair - Knox Daily
Potential Price Increase for Travere Therapeutics Inc (TVTX) After Recent Insider Activity - Knox Daily
N-able Inc (NABL) Becoming More Attractive for Investors - Knox Daily
Mersana Therapeutics Inc [MRSN] Investment Appeal on the Rise - Knox Daily
Raymond James gives a Mkt perform recommendation for ACV Auctions Inc (ACVA) - Knox Daily
SpringWorks Therapeutics Inc (SWTX) receives a Buy rating from Guggenheim - Knox Daily
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
The Potential Rise in the Price of Denali Therapeutics Inc (DNLI) following insiders activity - Knox Daily
Is Checkpoint Therapeutics Inc (NASDAQ: CKPT) Doomed To Fail? - Stocks Register
Investing in Viavi Solutions Inc (VIAV) Is Getting More Attractive - Knox Daily
Insider Selling Buzz: Arrowhead Pharmaceuticals Inc. [ARWR] Chief Commercial Officer Oliver Tracie sold 9,394 shares of the company – Knox Daily - Knox Daily
A company insider recently sold 25,000 shares of Adobe Inc [ADBE]. Should You also Consider to Sale? - Knox Daily
Wells Fargo gives an Overweight recommendation for Ventas Inc (VTR) - Knox Daily
Checkpoint Therapeutics Inc Azioni (CKPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):